Stephen Pyke

4.3k total citations · 2 hit papers
14 papers, 3.5k citations indexed

About

Stephen Pyke is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Statistics and Probability. According to data from OpenAlex, Stephen Pyke has authored 14 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Statistics and Probability. Recurrent topics in Stephen Pyke's work include Meta-analysis and systematic reviews (3 papers), Pharmaceutical industry and healthcare (3 papers) and Statistical Methods in Clinical Trials (3 papers). Stephen Pyke is often cited by papers focused on Meta-analysis and systematic reviews (3 papers), Pharmaceutical industry and healthcare (3 papers) and Statistical Methods in Clinical Trials (3 papers). Stephen Pyke collaborates with scholars based in United Kingdom, United States and Switzerland. Stephen Pyke's co-authors include Simon G. Thompson, F. Haverkate, Joachim Kienast, J.C.W. van de Loo, J. Ruth Gallimore, I. Juhan‐Vague, Jørgen Jespersen, Marie‐Christine Alessi, J.N. Pritchard and Malcolm Johnson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Stephen Pyke

13 papers receiving 3.3k citations

Hit Papers

Hemostatic Factors and the Risk of Myocardial Infarction ... 1995 2026 2005 2015 1995 1997 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
    1995 1.5k citations Simon G. Thompson, Joachim Kienast et al. New England Journal of Medicine profile →
  2. Production of C-reactive protein and risk of coronary events in stable and unstable angina
    1997 1.2k citations Simon G. Thompson, Stephen Pyke et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Pyke United Kingdom 9 1.3k 1.2k 928 902 575 14 3.5k
F. Haverkate Netherlands 32 899 0.7× 1.1k 0.9× 770 0.8× 1.8k 2.0× 541 0.9× 94 4.7k
Anetta Undas Poland 40 1.1k 0.9× 2.2k 1.8× 1.4k 1.6× 1.9k 2.1× 566 1.0× 282 6.3k
Tsutomu Tabata Japan 37 747 0.6× 1.2k 1.0× 1.2k 1.3× 613 0.7× 1.3k 2.2× 171 5.6k
Sabine Steiner Austria 35 564 0.4× 1.6k 1.3× 1.4k 1.5× 1.0k 1.2× 247 0.4× 145 4.0k
Renate Koppensteiner Austria 39 585 0.5× 2.1k 1.7× 2.3k 2.4× 1.8k 2.0× 389 0.7× 245 5.6k
Matteo Nicola Dario Di Minno Italy 49 1.3k 1.1× 1.7k 1.4× 1.4k 1.5× 568 0.6× 629 1.1× 274 8.2k
Siegmund Braun Germany 40 679 0.5× 3.5k 2.9× 2.1k 2.2× 671 0.7× 466 0.8× 128 6.8k
M Brozović United Kingdom 30 621 0.5× 869 0.7× 623 0.7× 1.4k 1.6× 595 1.0× 74 4.4k
Tomas Jogestrand Sweden 28 410 0.3× 1.1k 0.9× 875 0.9× 730 0.8× 244 0.4× 108 4.2k
Dong‐Wan Chae South Korea 35 534 0.4× 576 0.5× 594 0.6× 514 0.6× 298 0.5× 179 4.0k

Countries citing papers authored by Stephen Pyke

Since Specialization
Citations

This map shows the geographic impact of Stephen Pyke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Pyke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Pyke more than expected).

Fields of papers citing papers by Stephen Pyke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Pyke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Pyke. The network helps show where Stephen Pyke may publish in the future.

Co-authorship network of co-authors of Stephen Pyke

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Pyke. A scholar is included among the top collaborators of Stephen Pyke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Pyke. Stephen Pyke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pyke, Stephen, Steven A. Julious, Simon Day, et al.. (2011). The potential for bias in the reporting of industry sponsored trials.
2.
O’Kelly, Michael, Steven A. Julious, Stephen Pyke, et al.. (2010). Making available information from studies sponsored by the pharmaceutical industry: some current practices. Pharmaceutical Statistics. 10(1). 60–69. 6 indexed citations
3.
Pyke, Stephen, Steven A. Julious, Simon Day, et al.. (2010). The potential for bias in reporting of industry‐sponsored clinical trials. Pharmaceutical Statistics. 10(1). 74–79. 13 indexed citations
4.
Matcham, James, Steven A. Julious, Stephen Pyke, et al.. (2010). Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry‐sponsored clinical trials. Pharmaceutical Statistics. 10(1). 70–73. 13 indexed citations
5.
Nelson, Harold S., Kenneth R. Chapman, Stephen Pyke, Malcolm Johnson, & J.N. Pritchard. (2003). Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. Journal of Allergy and Clinical Immunology. 112(1). 29–36. 148 indexed citations
6.
Shrewsbury, Stephen B. & Stephen Pyke. (2002). MIASMA. CHEST Journal. 121(3). 1002–1003. 3 indexed citations
7.
Thompson, Simon G., et al.. (1997). Production of C-reactive protein and risk of coronary events in stable and unstable angina. The Lancet. 349(9050). 462–466. 1240 indexed citations breakdown →
8.
Thompson, Simon G., Stephen Pyke, & Rebecca Hardy. (1997). The design and analysis of paired cluster randomized trials: an application of meta-analysis techniques. Statistics in Medicine. 16(18). 2063–2079. 86 indexed citations
9.
Thompson, Simon G., Stephen Pyke, & David Wood. (1996). Using a coronary risk score for screening and intervention in general practice. Journal of Cardiovascular Risk. 3(3). 301–306. 6 indexed citations
10.
Juhan‐Vague, I., Stephen Pyke, Marie‐Christine Alessi, et al.. (1996). Fibrinolytic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients With Angina Pectoris. Circulation. 94(9). 2057–2063. 454 indexed citations
11.
Thompson, Simon G., Joachim Kienast, Stephen Pyke, F. Haverkate, & J.C.W. van de Loo. (1995). Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris. New England Journal of Medicine. 332(10). 635–641. 1483 indexed citations breakdown →
12.
Ames, Paul R. J., Stephen Pyke, Luigi Iannaccone, & Vincenzo Brancaccio. (1995). Antiphospholipid Antibodies, Haemostatic Variables and Thrombosis – A Survey of 144 Patients. Thrombosis and Haemostasis. 73(5). 768–773. 43 indexed citations
13.
Thompson, R. L., Stephen Pyke, Elizabeth Scott, Simon G. Thompson, & David A. Wood. (1993). Cigarette Smoking, Polyunsaturated Fats, and Coronary Heart Disease. Annals of the New York Academy of Sciences. 686(1). 130–138. 22 indexed citations
14.
Pyke, Stephen, et al.. (1993). Variability over Time of Haemostatic and Other Cardiovascular Risk Factors in Patients Suffering from Angina Pectoris. Thrombosis and Haemostasis. 70(5). 743–746. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Haverkate Breakdown of academic impact, for papers by Anetta Undas Breakdown of academic impact, for papers by Tsutomu Tabata Breakdown of academic impact, for papers by Sabine Steiner Breakdown of academic impact, for papers by Renate Koppensteiner Breakdown of academic impact, for papers by Matteo Nicola Dario Di Minno Breakdown of academic impact, for papers by Siegmund Braun Breakdown of academic impact, for papers by M Brozović Breakdown of academic impact, for papers by Tomas Jogestrand Breakdown of academic impact, for papers by Dong‐Wan Chae
Rankless by CCL
2026